Institutional investors purchased a net $8.3 million shares of NVO during the quarter ended June 2017, and now own 7.90% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FISHER ASSET MANAGEMENT LLC Bought 433.7 Thousand shares of Novo Nordisk
FIDELITY INVESTMENTS CANADA ULC Bought 125.7 Thousand shares of Novo Nordisk
RHENMAN & PARTNERS ASSET MANAGEM... Bought 80.0 Thousand shares of Novo Nordisk